Peri-operative Myocardial Injury in Patients Undergoing Surgery for Critical Limb Ischaemia  by Hobbs, S.D. et al.
Presented at
Society of Gre
*Correspondi
Vascular Su
Hospital and
Midlands B9
E-mail address
1078–5884/00Peri-operative Myocardial Injury in Patients Undergoing
Surgery for Critical Limb Ischaemia
S.D. Hobbs, M. Yapanis, P.J. Burns, A.B. Wilmink, A.W. Bradbury and D.J. Adam*University Department of Vascular Surgery, Birmingham Heartlands Hospital, Birmingham, UKIntroduction. Although up to a half of patients undergoing abdominal aortic aneurysm (AAA) repair suffer myocardial
injury, as indicated by a rise in cardiac troponin I (cTnI), this is infrequently accompanied by a rise in creatine kinase (CK)-
MB fraction or electrocardiogram (ECG) changes. This study compares for the first time peri-operative cTnI, CK-MB and
ECG changes in patients undergoing surgery for critical lower limb ischaemia (CLI).
Methods. Twenty-nine patients (20 men, median age 75 [range, 57–95] years) were studied prospectively. cTnI, CK/CK-
MB ratio and ECG were performed pre-operatively and on post-operative days 1, 2 and 3.
Results. Eleven (38%) patients had an elevated cTnIO0.5 ng/ml. Five (17%) patients had an elevated CK-MB fractionO
4% and all of these patients had an elevated cTnI. Eleven (38%) patients had ischaemic changes on ECG including seven of
11 (64%) patients with elevated cTnI and all five patients with elevated CK-MB fraction. There was no relationship between
pre-operative cardiac status, antiplatelet use or type of anaesthesia and post-operative cTnI rise. Patients with a cTnI rise
were younger (pZ0.01), and were more likely to have presented with gangrene (pZ0.04) and have a longer operation time
(pZ0.01) than patients who did not demonstrate a cTnI rise. Four patients developed clinically apparent cardiac
complications: cardio-pulmonary arrest (nZ1), cardiogenic shock (nZ1), acute CCF (nZ1) and rapid atrial fibrillation
(nZ1). Survival at 6 months was 26 of 29 (90%) patients.
Conclusion. These data demonstrate that over a third of patients operated for CLI sustain peri-operative myocardial injury,
many of which are not clinically apparent. Pre-operative medical optimisation may improve prognosis in this group of
patients.Keywords: Myocardial injury; Critical limb ischaemia; Troponin I.Introduction
Cardiovascular complications are the major cause of
morbidity and mortality in patients undergoing major
vascular surgery with myocardial infarction (MI)
accounting for over 50% of peri-operative deaths in
this group of patients. Cardiac troponin I (cTnI) is a
highly sensitive and specific marker of myocardial
injury. Previous work from this department has
demonstrated that over half of patients undergoing
emergency repair and more than a quarter of patients
undergoing elective repair of abdominal aortic aneur-
ysm (AAA) have evidence of myocardial injury as
indicated by a rise in serum cardiac troponin I (cTnI)the Annual General Meeting of the Vascular Surgical
at Britain and Ireland 2002 (Belfast, Northern Ireland).
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in the creatine kinase (CK):CK-MB ratio.1,3 Elevated
peri-operative cardiac troponin levels in patients
undergoing major vascular reconstruction has been
shown to be associated with an increase in the
incidence of myocardial infarction (MI) and all-cause
mortality during follow-up.4–6
This study compares cTnI, CK-MB and electrocar-
diographic (ECG) changes as markers of peri-operat-
ive myocardial injury in patients operated for critical
lower limb ischaemia (CLI), and determines the value
of cTnI as a marker of post-operative mortality in this
patient group.Patients and MethodsPatients
Twenty-nine patients (20 men and nine women of
median age 75 [range, 57–95] years) who underwentEur J Vasc Endovasc Surg 29, 301–304 (2005)
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were prospectively studied. Local ethical committee
approval was obtained and all patients gave written
informed consent. Co-morbidity data are shown in
Table 1.
CLI was defined as the presence of chronic
ischaemic rest pain, ulceration or gangrene. The
indication for intervention was rest pain (nZ12),
ulceration (nZ10) and digital gangrene (nZ7). Nine-
teen procedures were performed under general
anaesthesia and 10 under epidural or spinal anaes-
thesia. The revascularisation procedures performed
are shown in Table 2. The median (range) operating
time was 180 (75–300) min.Sample collection and analysis
Venous blood was collected into clot activator serum
tubes pre-operatively, 6 h post-operatively, and on the
mornings of post-operative days 1, 2 and 3. Blood
samples were allowed to clot at room temperature for
30 min before being centrifuged at 2500 rpm (1128g)
for 15 min. Serum was stored atK80 8C for later batch
analysis.
Serum cTnI was measured by enzyme-linked
immunosorbent assay (ELISA) (OPUS Troponin I;
Dade Behring, Deerfield, Illinois, USA) using a fully
automated OPUS II analyser (Dade Behring). The
lower limit of detection of cTnI using this technique is
0.5 ng/ml. cTnI values equal to or greater than
0.5 ng/ml in any of the four samples were considered
positive for myocardial injury. Troponin I has the
advantage over troponin T in that it is not influenced
by renal dysfunction or skeletal muscle CK.7,8 Tropo-
nin I is first detected 3–12 h following myocardial
necrosis, reaches peak levels at 12 h and is detectable
in the circulation for 5–10 days.9
Serum CK and its MB fraction (CK-MB) were
measured by a multi-point rate assay (Vitros 700 CK
and CK-MB slides; Johnson and Johnson, Rochester,
New York, USA). The lower limit of detection for CK-Table 1. Patient co-morbidity
Co-morbidity Number of patients
Hypertension 17
Angina pectoris 2
Previous myocardial infarction 2
Diabetes mellitus 13
Previous coronary artery bypass grafting 3
Previous peripheral vascular intervention 14
Medication
Anti-platelet therapy 16
Anticoagulation 3
Diuretic therapy 12
b-receptor antagonist 1
Eur J Vasc Endovasc Surg Vol 29, March 2005MB was 16 units/l. CK-MB fraction of greater than 4%
in any of the four samples was considered positive for
myocardial injury.Post-operative cardiac events
ECGs were performed at the same time as the blood
sampling; pre-operatively, 6 h postoperatively and on
the mornings of post-operative days 1, 2 and 3. ECG
evidence of myocardial ischaemia or infarction was
determined by a consultant cardiologist, who was
blinded to all other data. Peri-operative cardiac
complications were defined as: (1) Acute MI diag-
nosed by two of the following three criteria: history of
prolonged ischaemic-type chest pain, evolving ECG
changes and a rise in serial serum CK and CK-MB; (2)
Congestive cardiac failure (CCF) associated with
radiological evidence of pulmonary oedema; (3)
Cardiac arrhythmia requiring intervention to maintain
cardiovascular stability, and (4) Cardiac arrest and
cardiac death.Statistical analysis
Statistical analysis was performed using SPSS version
11.0.0 (Statistical Package for Social Sciences Inc,
Chicago, IL, USA). The Mann–Whitney U test and
Chi-squared test were used where appropriate. A
probability value of less than 0.05 was considered
statistically significant.Results
Eleven of 29 (38%) patients had an elevated post-
operative cTnI, and the time course for this rise is
shown in Fig. 1. No patient with a cTnI rise
complained of chest pain. CK:CK-MB ratio was
elevated in five patients, all of whom had an elevated
cTnI. Patients with a cTnI rise were younger (median
69 [range, 57–80] years vs. median 77.5 [range, 58–95]
years, pZ0.01), and were more likely to have pre-
sented with gangrene (pZ0.04) and have a longer
operation time (median 240 [range, 78–300] min vs.
median 159 [range, 75–240] min, pZ0.01) than patients
who did not demonstrate a cTnI rise. There was no
relationship between pre-operative cardiac status,
antiplatelet use or type of anaesthesia and post-
operative cTnI rise.
Eleven (38%) patients had post-operative evidence
of myocardial ischaemia on ECG but none were
diagnostic of MI. Seven of 11 (64%) patients with
elevated cTnI and all five patients with elevated
Table 2. Revascularisation procedures
Procedure Number of patients
Ilio-femoral bypassCabove-knee femoro-popliteal bypass 1
Ilio-femoral bypassCfemoro-distal bypass 2
Femoro-femoral cross-over bypass 1
Femoro-femoral cross-overCabove-knee femoro-popliteal bypass 1
Above-knee femoro-popliteal bypass 5
Below-knee femoro-popliteal bypass 2
Infra-popliteal bypass 17
Total 29
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patients with ECG changes had no CK:CK-MB rise.
Four patients had clinically apparent post-operative
cardiac complications. One patient, who had a pre-
operative cTnI level of 0.37 ng/ml, sustained a fatal
cardio-pulmonary arrest in the recovery room
immediately post-operatively. Another patient devel-
oped acute CCF on the first post-operative day with
evidence of ST segment depression on ECG. cTnI was
0.56 ng/ml pre-operatively and this increased to
26.4 ng/ml on post-operative day 2. This patient had
a further episode of CCF on post-operative day 7 but
was subsequently discharged home and was alive at 6
months. One patient developed rapid atrial fibrillation
within the first 24 h of surgery without an associated
rise in cTnI. One further patient, with a cTnI of
0.58 ng/ml on the first post-operative day, died on
post-operative day 14 from cardiogenic shock.
Twenty-six of 29 (90%) patients were alive at 6-Fig. 1. Time course of peri-operative cardiac troponin I (cTnI)
rise following surgery for critical limb ischaemia in those
patients with an elevation in cTnI. The upper limit of the
normal range for cTnI is !0.5 ng/ml. cTnI levels greater
than 0.5 ng/ml are considered positive for myocardial injury.months follow-up. One patient, with a cTnI level of
2.0 ng/ml on post-operative day 3, died at home 4
months after surgery from an unknown cause.Discussion
The major finding of the present study is that 38% of
patients undergoing surgical revascularisation for CLI
have evidence of peri-operative myocardial injury, as
demonstrated by elevated levels of cTnI. CK-MB
fraction and ECG significantly under-estimated the
incidence of myocardial injury: elevated CK-MB
fraction and ECG changes of ischaemia were present
in 45 and 64% of patients with elevated cTnI,
respectively.
The present study demonstrates that incidence of
peri-operative myocardial injury in patients with CLI
is similar to that in patients undergoing elective repair
of asymptomatic AAA.1 Pre-operative cardiac status,
antiplatelet use or type of anaesthesia had no demon-
strable effect on the incidence of post-operative
myocardial injury. Clinically apparent cardiac compli-
cations occurred in four of 29 (14%) patients and this is
considerably higher than the 3% incidence recently
reported in a large series of patients undergoing pedal
bypass for CLI.10 Three patients died in hospital or
within 6 months of surgery and all had an elevated
cTnI peri-operatively. In contrast to recent reports,
there was no relationship between elevated peri-
operative cTnI and an increased incidence of late
post-operative MI or death.4–6
Considerable evidence exists to support the use of
b-blockade and statin therapy in reducing the inci-
dence of early and late MI and cardiovascular deaths in
patients undergoing major vascular reconstruction.11–14
This and previous studies have demonstrated that best
medical therapy is frequently sub-optimal prior to
major vascular surgery.15 The effect of improved peri-
operative medical optimisation on peri-operative
myocardial injury and cTnI requires further
investigation.Eur J Vasc Endovasc Surg Vol 29, March 2005
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